Schedule 13G ownership disclosure

Regulus Therapeutics Inc.

Security class unavailable · CUSIP: 75915K101

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,779,174
Percent of class
7.7800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-15-000381
Form type
SC 13G
Filer
Regulus Therapeutics Inc.
CIK
CIK 1505512
Filed
Feb 12, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub